Endovascular reperfusion of M2 occlusions in acute ischemic stroke reduced disability and mortality: ETIS Registry results.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
May 2022
Historique:
received: 06 02 2021
accepted: 13 05 2021
pubmed: 29 5 2021
medline: 15 4 2022
entrez: 28 5 2021
Statut: ppublish

Résumé

The predictors of successful reperfusion and the effect of reperfusion after endovascular treatment (EVT) for M2 occlusions have not been well studied. We aimed to identify predictors of successful reperfusion and the effect of reperfusion on outcomes of EVT for M2 occlusions in current practice. Patients with acute ischemic stroke due to isolated M2 occlusions who were enrolled in the prospective multicenter Endovascular Treatment in Ischemic Stroke (ETIS) Registry in France between January 2015 and March 2020 were included. The primary outcome was a favorable outcome, defined as modified Rankin Scale (mRS) score of 0-2 at 90 days. Successful reperfusion was defined as an improvement of ≥1 points in the modified Thrombolysis In Cerebral Infarction score between the first and the last intracranial angiogram. A total of 458 patients were included (median National Institutes of Health Stroke Scale (NIHSS) score 14; 61.4% received prior intravenous thrombolysis). Compared with the non-reperfused patients, reperfused patients had an increased rate of excellent outcome (OR 2.3, 95% CI 0.98 to 5.36; p=0.053), favorable outcome (OR 2.79, 95% CI 1.31 to 5.93; p=0.007), and reduced 90-day mortality (OR 0.39, 95% CI 0.19 to 0.79; p<0.01). Admission NIHSS score was the only predictor of successful reperfusion. First-line strategy was not a predictor of successful reperfusion or favorable outcome, but the use of a stent retriever, alone or with an aspiration catheter, was associated with higher rates of procedural complications and 90-day mortality. Successful reperfusion of M2 occlusions reduced disability and mortality. However, safety is a concern, especially if the procedure failed.

Sections du résumé

BACKGROUND BACKGROUND
The predictors of successful reperfusion and the effect of reperfusion after endovascular treatment (EVT) for M2 occlusions have not been well studied. We aimed to identify predictors of successful reperfusion and the effect of reperfusion on outcomes of EVT for M2 occlusions in current practice.
METHODS METHODS
Patients with acute ischemic stroke due to isolated M2 occlusions who were enrolled in the prospective multicenter Endovascular Treatment in Ischemic Stroke (ETIS) Registry in France between January 2015 and March 2020 were included. The primary outcome was a favorable outcome, defined as modified Rankin Scale (mRS) score of 0-2 at 90 days. Successful reperfusion was defined as an improvement of ≥1 points in the modified Thrombolysis In Cerebral Infarction score between the first and the last intracranial angiogram.
RESULTS RESULTS
A total of 458 patients were included (median National Institutes of Health Stroke Scale (NIHSS) score 14; 61.4% received prior intravenous thrombolysis). Compared with the non-reperfused patients, reperfused patients had an increased rate of excellent outcome (OR 2.3, 95% CI 0.98 to 5.36; p=0.053), favorable outcome (OR 2.79, 95% CI 1.31 to 5.93; p=0.007), and reduced 90-day mortality (OR 0.39, 95% CI 0.19 to 0.79; p<0.01). Admission NIHSS score was the only predictor of successful reperfusion. First-line strategy was not a predictor of successful reperfusion or favorable outcome, but the use of a stent retriever, alone or with an aspiration catheter, was associated with higher rates of procedural complications and 90-day mortality.
CONCLUSIONS CONCLUSIONS
Successful reperfusion of M2 occlusions reduced disability and mortality. However, safety is a concern, especially if the procedure failed.

Identifiants

pubmed: 34045317
pii: neurintsurg-2021-017380
doi: 10.1136/neurintsurg-2021-017380
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Michel Piotin (M)
Raphael Blanc (R)
Hocine Redjem (H)
Simon Escalard (S)
Jean-Philippe Dessilles (JP)
François Delvoye (F)
Stanislas Smajda (S)
Benjamin Maier (B)
Hebert Solène (H)
Mikael Mazighi (M)
Mikael Obadia (M)
Candice Sabben (C)
Pierre Seners (P)
Igor Raynouard (I)
Ovide Corabianu (O)
Thomas de Broucker (T)
Eric Manchon (E)
Guillaume Taylor (G)
Malek Ben Maacha (MB)
Laurie-Anne Thion (LA)
Augustin Lecler (A)
Julien Savatovsjy (J)
Adrien Wang (A)
Serge Evrard (S)
Maya Tchikviladze (M)
Nadia Ajili (N)
Bertrand Lapergue (B)
David WeisenburgerLile (D)
Lucas Gorza (L)
Géraldine Buard (G)
Oguzhan Coskun (O)
Arturo Consoli (A)
Federico Di Maria (FD)
Georges Rodesh (G)
Sergio Zimatore (S)
Morgan Leguen (M)
Julie Gratieux (J)
Fernando Pico (F)
Haja Rakotoharinandrasana (H)
Philippe Tassan (P)
Roxanna Poll (R)
Sylvie Marinier (S)
Gaultier Marnat (G)
Florent Gariel (F)
Xavier Barreau (X)
Jérôme Berge (J)
Patrice Menegon (P)
Igor Sibon (I)
Ludovic Lucas (L)
Stéphane Olindo (S)
Pauline Renou (P)
Sharmila Sagnier (S)
Mathilde Poli (M)
Sabrina Debruxelles (S)
François Rouanet (F)
Thomas Tourdias (T)
Jean-Sebastien Liegey (JS)
Pierre Briau (P)
Nicolas Pangon (N)
Romain Bourcier (R)
Lili Detraz (L)
Benjamin Daumas-Duport (B)
Pierre-Louis Alexandre (PL)
Monica Roy (M)
Cédric Lenoble (C)
Hubert Desal (H)
Benoît Guillon (B)
Solènede Gaalon (S)
Cécile Preterre (C)
Benjamin Gory (B)
Serge Bracard (S)
René Anxionnat (R)
Marc Braun (M)
Anne-Laure Derelle (AL)
Romain Tonnelet (R)
Liang Liao (L)
François Zhu (F)
Emmanuelle Schmitt (E)
Sophie Planel (S)
Sébastien Richard (S)
Lisa Humbertjean (L)
Gioia Mione (G)
Jean-Christophe Lacour (JC)
Nolwenn Riou-Comte (N)
Gérard Audibert (G)
Marcela Voicu (M)
Lionel Alb (L)
Marie Reitter (M)
Madalina Brezeanu (M)
Agnès Masson (A)
Adriana Tabarna (A)
Iona Podar (I)
Sarah Guy (S)
Fatiha Bechiri (F)
Francisco Macian-Montoro (F)
Suzanna Saleme (S)
Charbel Mounayer (C)
Aymeric Rouchaud (A)
Laetitia Gimenez (L)
Alexandre Cosnard (A)
Vincent Costalat (V)
Caroline Arquizan (C)
Cyril Dargazanli (C)
Grégory Gascou (G)
Pierre-Henri Lefèvre (PH)
Imad Derraz (I)
Carlos Riquelme (C)
Nicolas Gaillard (N)
Isabelle Mourand (I)
Lucas Corti (L)
Federico Cagnazzo (F)
Adrienter Schiphorst (A)
Francois Eugene (F)
Stéphane Vannier (S)
Jean-Christophe Ferre (JC)
Hélène Raoult (H)
Thomas Ronziere (T)
Maria Lassale (M)
Christophe Paya (C)
Jean-Yves Gauvrit (JY)
Clément Tracol (C)
Sophie Langnier-Lemercier (S)
Axelle Maurice (A)
Sabrina Cochennec (S)
Mélanie Pinault (M)
Eimad Shotar (E)
Nader Sourour (N)
Stéphanie Lenck (S)
Kévin Premat (K)
Yves Samson Anne Léger (YSA)
Sophie Crozier (S)
Flore Baronnet (F)
Sonia Alamowitch (S)
Laure Bottin (L)
Mathon Yger (M)
Vincent Degos (V)
Laurent Spelle (L)
Christian Denier (C)
Olivier Chassin (O)
Vanessa Chalumeau (V)
Jildaz Caroff (J)
Olivier Chassin (O)
Laura Venditti (L)
Mariana Sarov (M)
Nicolas Legris (N)
Olivier Naggara (O)
Wagih Ben Hassen (WB)
Grégoire Boulouis (G)
Christine Rodriguez-Régent (C)
Denis Trystram (D)
Basile Kerleroux (B)
Guillaume Turc (G)
Pierre Seners (P)
Valérie Domigo (V)
Catherine Lamy (C)
Julia Birchenall (J)
Clothilde Isabel (C)
François Lun (F)
Alain Viguier (A)
Christophe Cognard (C)
Anne Christine Januel (AC)
Jean-Marc Olivot (JM)
Louis Fontaine (L)
Nicolas Raposo (N)
Fabrice Bonneville (F)
Jean François Albucher (JF)
Lionel Calviere (L)
Jean Darcourt (J)
Guillaume Bellanger (G)
Philippe Tall (P)
Emmanuel Touze (E)
Charlotte Barbier (C)
Romain Schneckenburger (R)
Marion Boulanger (M)
Julien Cogez (J)
Sophie Guettier (S)
Maxime Gauberti (M)
Serge Timsit (S)
Jean-Christophe Gentric (JC)
Julien Ognard (J)
Francois Mathias Merrien (FM)
OzlemOzku Wermester (O)
Evelyne Massardier (E)
Chrysanthi Papagiannaki (C)
Aude Triquenot (A)
Margeaux Lefebvre (M)
Frédéric Bourdain (F)
Patricia Bernady (P)
Laurent Lagoarde-Segot (L)
Hélène Cailliez (H)
Louis Veunac (L)
David Higue (D)
Valérie Wolff (V)
Veronique Quenardelle (V)
Valerie Lauer (V)
Roxana Gheoca (R)
Irene Pierre-Paul (I)
Raoul Pop (R)
Remy Beaujeux (R)
Dan Mihoc (D)
Monica Manisor (M)
Julien Pottecher (J)
Alain Meyer (A)
Thiên-Nga Chamaraux-Tran (TN)
Anthony Le Bras (AL)
Sarah Evain (S)
Arnaud Le Guen (A)

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: BL reports grants from Stryker, Penumbra, and Microvention.

Auteurs

Patricio Muszynski (P)

Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, CHRU-Nancy, Nancy, France.

Mohammad Anadani (M)

Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
Neurology, Medical University of South Carolina - College of Medicine, Charleston, South Carolina, USA.

Sébastien Richard (S)

Neurology, Stroke Unit, Université de Lorraine, CHRU-Nancy, Nancy, France.

Gaultier Marnat (G)

Interventional and Diagnostic Neuroradiology, CHU Bordeaux, Bordeaux, France.

Romain Bourcier (R)

Neuroradiology, University Hospital of Nantes, Nantes, France.

Igor Sibon (I)

Neurology, Stroke Unit, CHU Bordeaux, Bordeaux, France.

Cyril Dargazanli (C)

Neuroradiology, CHRU Gui de Chauliac, Montpellier, France.

Caroline Arquizan (C)

Neurology, CHRU Gui de Chauliac, Montpellier, France.

Benjamin Maïer (B)

Interventional Neuroradiology, Rothschild Foundation, Paris, France.

Raphaël Blanc (R)

Interventional Neuroradiology, Rothschild Foundation, Paris, France.

Bertrand Lapergue (B)

Neurology, Stroke Unit, Foch Hospital, Suresnes, France.

Arturo Consoli (A)

Diagnostic and Therapeutic Neuroradiology, Foch Hospital, Suresnes, France.

Francois Eugene (F)

Neuroradiology, CHU Rennes, Rennes, France.

Stephane Vannier (S)

Neurology, Stroke Unit, CHU Rennes, Rennes, France.

Laurent Spelle (L)

Interventional Neuroradiolology, CHU Bicêtre, Le Kremlin-Bicêtre, France.

Christian Denier (C)

Neurology, Stroke Unit, CHU Bicêtre, Le Kremlin-Bicêtre, France.

Marion Boulanger (M)

Neurology, Stroke Unit, CHU Caen, Caen, France.

Maxime Gauberti (M)

Neuroradiolology, CHU Caen, Caen, France.

Suzana Saleme (S)

Neuroradiology, CHU Limoges, Limoges, France.

Francisco Macian (F)

Neurology, Stroke Unit, CHU Limoges, Limoges, France.

Frédéric Clarençon (F)

Sorbonne Université, Paris, France.
Neuroradiology, CHU Pitié-Salpêtrière, Paris, France.

Charlotte Rosso (C)

Neurology, Stroke Unit, CHU Pitié-Salpêtrière, Paris, France.

Olivier Naggara (O)

Neuroradiology, Hôpital St Anne, Paris, France.

Guillaume Turc (G)

Neurology, Stroke Unit, Hôpital Saint Anne, Paris, France.

Ozlem Ozkul-Wermester (O)

Neurology, Stroke Unit, CHU Rouen, Rouen, France.

Chrisanthi Papagiannaki (C)

Interventional Neuroradiolology, CHU Rouen, Rouen, France.

Alain Viguier (A)

Neurology, Stroke Unit, CHU Toulouse, Toulouse, France.

Christophe Cognard (C)

Diagnostic and Therapeutic Neuroradiology, CHU Toulouse, Toulouse, France.

Anthony Le Bras (A)

Radiology, CH Bretagne Atlantique, Vannes, France.

Sarah Evain (S)

Neurology, Stroke Unit, CH Bretagne Atlantique, Vannes, France.

Valérie Wolff (V)

Stroke Unit, CHU Strasbourg, Strasbourg, France.

Raoul Pop (R)

Interventional Neuroradiolology, CHU Strasbourg, Strasbourg, France.

Serge Timsit (S)

Neurology, Stroke Unit, CHU Brest, Brest, France.

Jean-Christophe Gentric (JC)

Interventionl Neuroradiolology, CHU Brest, Brest, France.

Frédéric Bourdain (F)

Neurology, Stroke Unit, CH Côte Basque, Bayonne, France.

Louis Veunac (L)

Radiolology, CH Côte Basque, Bayonne, France.

Benjamin Gory (B)

Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, CHRU-Nancy, Nancy, France b.gory@chu-nancy.fr.
IADI, INSERM U1254, Université de Lorraine, Nancy, France.

Stephanos Nikolaos Finitsis (SN)

Neuroradiolology, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece.
Radiology, Centre Hospitalier de L'Universite de Montreal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH